The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

People on weight-loss drugs often lose muscle mass while they lose weight, but new scientific findings suggest boosting your ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...

Semaglutide, a GLP-1R agonist developed by Denmark’s Novo Nordisk as Ozempic, initially for type 2 diabetes, and marketed ...

Cipla is looking at the whole GLP-1 category and not just Semaglutide alone, says Cipla CEO Umang Vohra in a post-results ...

The illicit supply of unregulated weight loss drugs is becoming an ‘emerging concern’ for Police Scotland and the.

WOMEN and older adults who use increasingly popular weight-loss drug semaglutide could protect themselves from a common side ...